Home › Heart Diseases › Wisconsin › Milwaukee
Heart Diseases clinical trials in Milwaukee, WI
5 studies for Heart Diseases are looking for participants at sites in and around Milwaukee (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Recruiting
- Aurora Medical Group, Milwaukee
ELEVATE-HFpEF Clinical Study
Recruiting
- Froedtert Hospital, Milwaukee
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Recruiting
- Aurora St. Luke's Medical Center, Milwaukee
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Recruiting
- Advocate Aurora St. Luke's, Milwaukee
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Recruiting
- Advocate Aurora Research Institute, Milwaukee
About Heart Diseases
Heart disease is the leading cause of death in the U.S. Learn about the different types of heart diseases, and what you can do to try to prevent them.
More about Heart Diseases on MedlinePlus
Heart Diseases trials in other cities
- New York City, NY17 studies
- Boston, MA13 studies
- Dallas, TX12 studies
- Cleveland, OH12 studies
- Los Angeles, CA11 studies
- Philadelphia, PA11 studies
- Portland, OR10 studies
- Pittsburgh, PA10 studies
- Durham, NC10 studies
- Rochester, MN10 studies
- Indianapolis, IN10 studies
- St. Louis, MO9 studies
Other studies in Milwaukee
- Cancer (all types)24 studies
- Multiple Myeloma23 studies
- Breast Cancer22 studies
- Non-Small Cell Lung Cancer21 studies
- Lung Cancer21 studies
- Non-Hodgkin Lymphoma19 studies
- Follicular Lymphoma19 studies
- Prostate Cancer19 studies
- Acute Myeloid Leukemia18 studies
- Pancreatic Cancer18 studies
- Ovarian Cancer17 studies
- Diffuse Large B-Cell Lymphoma17 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.